These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 10691817

  • 1. Oxybutynin for detrusor instability with adjuvant salivary stimulant pastilles to improve compliance: results of a multicentre, randomized controlled trial.
    Tincello DG, Adams EJ, Sutherst JR, Richmond DH.
    BJU Int; 2000 Mar; 85(4):416-20. PubMed ID: 10691817
    [Abstract] [Full Text] [Related]

  • 2. The use of salivary stimulant pastilles to improve compliance in women taking oxybutynin hydrochloride for detrusor instability: a pilot study.
    Hooper P, Tincello DG, Richmond DH.
    Br J Urol; 1997 Sep; 80(3):414-6. PubMed ID: 9313659
    [Abstract] [Full Text] [Related]

  • 3. Which anticholinergic drug for overactive bladder symptoms in adults.
    Hay-Smith J, Herbison P, Ellis G, Morris A.
    Cochrane Database Syst Rev; 2005 Jul 20; (3):CD005429. PubMed ID: 16034974
    [Abstract] [Full Text] [Related]

  • 4. Dry mouth with conventional and controlled-release oxybutynin in urinary incontinence. The Ditropan XL Study Group.
    Versi E, Appell R, Mobley D, Patton W, Saltzstein D.
    Obstet Gynecol; 2000 May 20; 95(5):718-21. PubMed ID: 10775736
    [Abstract] [Full Text] [Related]

  • 5. Quantitative characterization of therapeutic index: application of mixed-effects modeling to evaluate oxybutynin dose-efficacy and dose-side effect relationships.
    Gupta SK, Sathyan G, Lindemulder EA, Ho PL, Sheiner LB, Aarons L.
    Clin Pharmacol Ther; 1999 Jun 20; 65(6):672-84. PubMed ID: 10391673
    [Abstract] [Full Text] [Related]

  • 6. An extended-release formulation of oxybutynin chloride for the treatment of overactive urinary bladder.
    Goldenberg MM.
    Clin Ther; 1999 Apr 20; 21(4):634-42. PubMed ID: 10363730
    [Abstract] [Full Text] [Related]

  • 7. [Assessment of effectiveness of and tolerance to oxybutynin in the treatment of unstable bladder in women].
    Serrano Brambila EA, Quiroga Avila RG, Lorenzo Monterrubio JL, Moreno Aranda J.
    Ginecol Obstet Mex; 2000 Apr 20; 68():174-81. PubMed ID: 10824450
    [Abstract] [Full Text] [Related]

  • 8. Trospium chloride for the treatment of overactive bladder with urge incontinence.
    Singh-Franco D, Machado C, Tuteja S, Zapantis A.
    Clin Ther; 2005 May 20; 27(5):511-30. PubMed ID: 15978301
    [Abstract] [Full Text] [Related]

  • 9. A placebo-controlled, multicentre study comparing the tolerability and efficacy of propiverine and oxybutynin in patients with urgency and urge incontinence.
    Madersbacher H, Halaska M, Voigt R, Alloussi S, Höfner K.
    BJU Int; 1999 Oct 20; 84(6):646-51. PubMed ID: 10510109
    [Abstract] [Full Text] [Related]

  • 10. Trospium chloride and oxybutynin hydrochloride in a german study of adults with urinary urge incontinence: results of a 12-week, multicenter, randomized, double-blind, parallel-group, flexible-dose noninferiority trial.
    Zellner M, Madersbacher H, Palmtag H, Stöhrer M, Bödeker RH, P195 Study Group.
    Clin Ther; 2009 Nov 20; 31(11):2519-39. PubMed ID: 20109997
    [Abstract] [Full Text] [Related]

  • 11. Treatment of detrusor instability with oxybutynin rectal suppositories.
    Winkler HA, Sand PK.
    Int Urogynecol J Pelvic Floor Dysfunct; 1998 Nov 20; 9(2):100-2. PubMed ID: 9694139
    [Abstract] [Full Text] [Related]

  • 12. The use of salivary stimulant pastilles to improve compliance in women taking oxybutinin hydrochloride for detrusor instability.
    Arango O.
    Br J Urol; 1998 Apr 20; 81(4):652. PubMed ID: 9598656
    [No Abstract] [Full Text] [Related]

  • 13. A double-blind randomized dose-response study comparing daily doses of 5, 10 and 15 mg controlled-release oxybutynin: balancing efficacy with severity of dry mouth.
    Corcos J, Casey R, Patrick A, Andreou C, Miceli PC, Reiz JL, Harsanyi Z, Darke AC, Uromax Study Group.
    BJU Int; 2006 Mar 20; 97(3):520-7. PubMed ID: 16469019
    [Abstract] [Full Text] [Related]

  • 14. A randomized, double-blind, parallel-group comparison of controlled- and immediate-release oxybutynin chloride in urge urinary incontinence.
    Barkin J, Corcos J, Radomski S, Jammal MP, Miceli PC, Reiz JL, Harsanyi Z, Darke AC, UROMAX Study Group.
    Clin Ther; 2004 Jul 20; 26(7):1026-36. PubMed ID: 15336467
    [Abstract] [Full Text] [Related]

  • 15. A randomized controlled trial comparing the efficacy of controlled-release oxybutynin tablets (10 mg once daily) with conventional oxybutynin tablets (5 mg twice daily) in patients whose symptoms were stabilized on 5 mg twice daily of oxybutynin.
    Birns J, Lukkari E, Malone-Lee JG.
    BJU Int; 2000 May 20; 85(7):793-8. PubMed ID: 10792154
    [Abstract] [Full Text] [Related]

  • 16. Clinical efficacy of oxybutynin on sensory urgency as compared with that on motor urgency.
    Hashimoto K, Ohnishi N, Esa A, Sugiyama T, Park Y, Kurita T.
    Urol Int; 1999 May 20; 62(1):12-6. PubMed ID: 10436424
    [Abstract] [Full Text] [Related]

  • 17. [Therapeutic effects of intrarectal administration of oxybutynin].
    Radziszewski P, Borkowski A.
    Wiad Lek; 2002 May 20; 55(11-12):691-8. PubMed ID: 12715351
    [Abstract] [Full Text] [Related]

  • 18. Controlled, double-blind, multicentre clinical trial to investigate long-term tolerability and efficacy of trospium chloride in patients with detrusor instability.
    Halaska M, Ralph G, Wiedemann A, Primus G, Ballering-Brühl B, Höfner K, Jonas U.
    World J Urol; 2003 May 20; 20(6):392-9. PubMed ID: 12811500
    [Abstract] [Full Text] [Related]

  • 19. Tolterodine: a clinical review.
    Crandall C.
    J Womens Health Gend Based Med; 2001 Oct 20; 10(8):735-43. PubMed ID: 11703885
    [Abstract] [Full Text] [Related]

  • 20. Urodynamic changes associated with behavioral and drug treatment of urge incontinence in older women.
    Goode PS, Burgio KL, Locher JL, Umlauf MG, Lloyd LK, Roth DL.
    J Am Geriatr Soc; 2002 May 20; 50(5):808-16. PubMed ID: 12028165
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.